| Stage | MA | % of rev | DHR | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $9.8B | 100.00% | $6.6B | 100.00% | MA ×1.50 |
| Gross profit | $9.8B | 100.00% | $3.8B | 58.54% | MA +41.5pp |
| Operating income | $5.9B | 59.77% | $1.2B | 19.00% | MA +40.8pp |
| Pre-tax income | $5.7B | 58.54% | $1.1B | 17.27% | MA +41.3pp |
| Net income | $4.6B | 47.19% | $1.2B | 18.84% | MA +28.3pp |
| Stage | MA | DHR | Gap · A − B |
|---|---|---|---|
| Revenue | $9.8B100.00% | $6.6B100.00% | MA ×1.50 |
| Gross profit | 100.00%$9.8B | 58.54%$3.8B | MA +41.5pp |
| Operating income | 59.77%$5.9B | 19.00%$1.2B | MA +40.8pp |
| Pre-tax income | 58.54%$5.7B | 17.27%$1.1B | MA +41.3pp |
| Net income |
| 47.19%$4.6B |
| 18.84%$1.2B |
| MA +28.3pp |
No disclosed counterparties: DHR.
None